Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIM: Vinorelbine in Relapsed Malignant Pleural Mesothelioma
NCT02139904Phase 2Completed
- Sponsor
- Wales Cancer Trials Unit
- Start
- Mar 2016
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine in malignant pleural mesothelioma (MPM), sponsored by Wales Cancer Trials Unit. Started Mar 2016; status: completed.
02
Drugs
vinorelbine
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT02139904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02139904.